Abstract
Owing to their inherent structural features, certain sulfated glycans isolated from terrestrial or marine mammals or invertebrates, can exert therapeutic properties against infections caused by pathogenic microorganisms like bacteria, virus, fungus, and protozoan parasites. These sulfated glycans belong to a variety of classes including glycosaminoglycans (GAGs) like chondroitin sulfate, fucosylated chondroitin sulfate, dermatan sulfate, unfractionated heparin, low-molecular-weight heparin, and acharan sulfate; and the less-famous algal polysaccharides known as sulfated fucans (including fucoidans), sulfated galactans (agarans and carrageenans), and sulfated heteropolysaccharides. Administration at certain concentrations of the antimicrobial sulfated glycans, especially those containing the higher amounts of the bioactive structural requirements, can lead to the interruption or disruption of the pathogen protein-host GAG complex formation, leading thus to the decrease or impairment of the microbial binding onto host cells. This report aims at presenting the current background concerning the therapeutic effects of the above-mentioned sulfated glycans as new antimicrobial agents. When sufficient data are available, discussion regarding structure-activity relationship is provided.
Keywords: Antibacterial, Antifungal, Antiprotozoan, Antiviral, Carbohydrate-based drug discovery, Carbohydrate-based drug development, Glycosaminoglycans, Sulfated glycans.
Current Topics in Medicinal Chemistry
Title:Antimicrobial Sulfated Glycans: Structure and Function
Volume: 17 Issue: 3
Author(s): Vitor H. Pomin
Affiliation:
Keywords: Antibacterial, Antifungal, Antiprotozoan, Antiviral, Carbohydrate-based drug discovery, Carbohydrate-based drug development, Glycosaminoglycans, Sulfated glycans.
Abstract: Owing to their inherent structural features, certain sulfated glycans isolated from terrestrial or marine mammals or invertebrates, can exert therapeutic properties against infections caused by pathogenic microorganisms like bacteria, virus, fungus, and protozoan parasites. These sulfated glycans belong to a variety of classes including glycosaminoglycans (GAGs) like chondroitin sulfate, fucosylated chondroitin sulfate, dermatan sulfate, unfractionated heparin, low-molecular-weight heparin, and acharan sulfate; and the less-famous algal polysaccharides known as sulfated fucans (including fucoidans), sulfated galactans (agarans and carrageenans), and sulfated heteropolysaccharides. Administration at certain concentrations of the antimicrobial sulfated glycans, especially those containing the higher amounts of the bioactive structural requirements, can lead to the interruption or disruption of the pathogen protein-host GAG complex formation, leading thus to the decrease or impairment of the microbial binding onto host cells. This report aims at presenting the current background concerning the therapeutic effects of the above-mentioned sulfated glycans as new antimicrobial agents. When sufficient data are available, discussion regarding structure-activity relationship is provided.
Export Options
About this article
Cite this article as:
Pomin H. Vitor, Antimicrobial Sulfated Glycans: Structure and Function, Current Topics in Medicinal Chemistry 2017; 17 (3) . https://dx.doi.org/10.2174/1568026615666150605104444
DOI https://dx.doi.org/10.2174/1568026615666150605104444 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions
Recent Patents on CNS Drug Discovery (Discontinued) Bcl-2 Family Proteins as Therapeutic Targets
Current Pharmaceutical Design Tumorspheres Derived from HCC Cells are Enriched with Cancer Stem Cell-like Cells and Present High Chemoresistance Dependent on the Akt Pathway
Anti-Cancer Agents in Medicinal Chemistry Anticancer Vitamin K3 Analogs: A Review
Anti-Cancer Agents in Medicinal Chemistry Bitter Gourd (Momordica charantia) is a Cornucopia of Health: A Review of its Credited Antidiabetic, Anti-HIV, and Antitumor Properties
Current Molecular Medicine Multi-Classifier Based on Hard Instances- New Method for Prediction of Human Immunodeficiency Virus Drug Resistance
Current Topics in Medicinal Chemistry A hypothesis for the role of RECK in angiogenesis
Current Vascular Pharmacology Dual-Specificity MAP Kinase Phosphatases as Targets of Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry SCF E3 Ubiquitin Ligases as Anticancer Targets
Current Cancer Drug Targets Image-Guided Nanoparticle-Based siRNA Delivery for Cancer Therapy
Current Pharmaceutical Design Discovery of MAO-B Inhibitors - Present Status and Future Directions Part I: Oxygen Heterocycles and Analogs
Mini-Reviews in Medicinal Chemistry Peroxisome Proliferator-Activated Receptors: Role of Isoform Gamma in the Antineoplastic Effect of Iodine in Mammary Cancer
Current Cancer Drug Targets Current Pathogenesis of Alzheimer’s Disease and Plants Derived Neuroprotective Phytoconstituents: A Comprehensive Review
Current Psychopharmacology Leukocyte P2 Receptors: A Novel Target for Anti-inflammatory and Antitumor Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Solubility Enhancement and Delivery Systems of Curcumin a Herbal Medicine: A Review
Current Drug Delivery Garlic-Derived Allyl Sulfides in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry An Overview of Published Papers and Important Developments in the Past Three Years
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cancer T Cell Immunotherapy with Bispecific Antibodies and Chimeric Antigen Receptors
Recent Patents on Anti-Cancer Drug Discovery Peptide Therapeutics in Neurodegenerative Disorders
Current Medicinal Chemistry MIIP, a Cytoskeleton Regulator that Blocks Cell Migration and Invasion, Delays Mitosis, and Suppresses Tumorogenesis
Current Protein & Peptide Science